Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Benign prostatic hyperplasia and prostate cancer.

× No keyword cloud information.

24 in total

1. Risk of prostate cancer associated with benign prostate disease: a primary care case-control study.

Authors: Brian S Buckley; Marie Carmela M Lapitan; Colin R Simpson; Aziz Sheikh
Journal: Br J Gen Pract Date: 2011-11 Impact factor: 5.386

2. Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.

Authors: Aruna V Sarma; Jennifer L St Sauver; John M Hollingsworth; Debra J Jacobson; Michaela E McGree; Rodney L Dunn; Michael M Lieber; Steven J Jacobsen
Journal: Urology Date: 2011-11-23 Impact factor: 2.649

Review 3. The link between benign prostatic hyperplasia and prostate cancer.

Authors: David D Ørsted; Stig E Bojesen
Journal: Nat Rev Urol Date: 2012-11-20 Impact factor: 14.432

Review 4. Testosterone Replacement Therapy on the Natural History of Prostate Disease.

Authors: Aaron Moore; Michael J Butcher; Tobias S Köhler
Journal: Curr Urol Rep Date: 2015-08 Impact factor: 3.092

5. Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.

Authors: Mohamed S Fawzy; Randa H Mohamed; Abdel-Rahman R Elfayoumi
Journal: Med Oncol Date: 2015-02-20 Impact factor: 3.064

6. Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study.

Authors: Thierry Gil; Fouad Aoun; Patrick Cabri; Valérie Perrot; Roland van Velthoven
Journal: Ther Adv Urol Date: 2017-06-21

7. Clinical features of prostate cancer before diagnosis: a population-based, case-control study.

Authors: William Hamilton; Deborah J Sharp; Tim J Peters; Alison P Round
Journal: Br J Gen Pract Date: 2006-10 Impact factor: 5.386

8. A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer.

Authors: Thierry Gil; Fouad Aoun; Patrick Cabri; Pascal Maisonobe; Roland van Velthoven
Journal: Ther Adv Urol Date: 2015-06

9. Joint effects of inflammation and androgen metabolism on prostate cancer severity.

Authors: Timothy R Rebbeck; Hanna Rennert; Amy H Walker; Saarene Panossian; Teo Tran; Kyle Walker; Elaine Spangler; Margerie Patacsil-Coomes; Rajeev Sachdeva; Alan J Wein; S Bruce Malkowicz; Charnita Zeigler-Johnson
Journal: Int J Cancer Date: 2008-09-15 Impact factor: 7.396

10. Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer.

Authors: Weibing Zhang; Xinming Zheng; Xinghuan Wang
Journal: Am J Cancer Res Date: 2015-08-15 Impact factor: 6.166